Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210
- Missing Citation
References
- Martins, A.M.; Gomes, A.L.; Vilas Boas, I.; Marto, J.; Ribeiro, H.M. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210. [Google Scholar] [CrossRef]
- Muller, C.; Morales, P.; Reggio, P.H. Cannabinoid Ligands Targeting TRP Channels. Front. Mol. Neurosci. 2019, 11, 487. [Google Scholar] [CrossRef]
- Mnekin, L.; Ripoll, L. Topical Use of Cannabis sativa L. Biochemicals. Cosmetics 2021, 8, 85. [Google Scholar]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Martins, A.M.; Gomes, A.L.; Boas, I.V.; Marto, J.; Ribeiro, H.M. Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210. Pharmaceuticals 2022, 15, 849. https://doi.org/10.3390/ph15070849
Martins AM, Gomes AL, Boas IV, Marto J, Ribeiro HM. Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210. Pharmaceuticals. 2022; 15(7):849. https://doi.org/10.3390/ph15070849
Chicago/Turabian StyleMartins, Ana M., Ana L. Gomes, Inês Vilas Boas, Joana Marto, and Helena M. Ribeiro. 2022. "Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210" Pharmaceuticals 15, no. 7: 849. https://doi.org/10.3390/ph15070849
APA StyleMartins, A. M., Gomes, A. L., Boas, I. V., Marto, J., & Ribeiro, H. M. (2022). Correction: Martins et al. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 2022, 15, 210. Pharmaceuticals, 15(7), 849. https://doi.org/10.3390/ph15070849